Show simple item record

FieldValueLanguage
dc.contributor.authorBell, Katy J.L.
dc.contributor.authorHayen, Andrew
dc.contributor.authorMacaskill, Petra
dc.contributor.authorIrwig, Les
dc.contributor.authorCraig, Jonathan C
dc.contributor.authorBauer, Douglas C
dc.date.accessioned2021-02-11T05:10:56Z
dc.date.available2021-02-11T05:10:56Z
dc.date.issued2009en
dc.identifier.urihttps://hdl.handle.net/2123/24507
dc.description.abstractTo assess the value of monitoring response to bisphosphonate treatment by means of measuring bone mineral density. In this paper we investigate the effects of alendronate on bone density at the individual level. We compare the variability of bone density for patients receiving placebo with that for patients taking treatment, using mixed models12 to make inferences about whether the effect of treatment varies among individuals or is uniform. Between-person (treatment related) variation and within-person (measurement related) variation in hip and spine bone mineral density.en
dc.language.isoenen
dc.publisherBMJ Publishing Groupen
dc.relation.ispartofBritish Medical Journalen
dc.rightsCreative Commons Attribution-NonCommercial 4.0en
dc.subjectmonitoringen
dc.subjectosteoporosisen
dc.subjectmenopauseen
dc.subjectbone mineral densityen
dc.titleValue of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.en
dc.typeArticleen
dc.subject.asrc1117 Public Health and Health Servicesen
dc.identifier.doi10.1136/bmj.b2266
dc.relation.nhmrc457212
dc.relation.nhmrc402764
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Healthen
usyd.citation.volume338en
usyd.citation.issue7710en
usyd.citation.spageb2266en
workflow.metadata.onlyNoen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.